Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Jul 01, 2017
Self-Association of Rafoxanide in Aqueous Media and Its Application in Preparing Amorphous Solid Dispersions
Read more
Scientific Article
/ May 30, 2017
Biomimetic Dissolution: A Tool to Predict Amorphous Solid Dispersion Performance
Read more
Scientific Article
Scientific Article